Search

everythinglearnresearchcommunity

for

Search:↓

Natural small molecules can help treat diseases by activating or inhibiting the Wnt pathway.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

The study created 3D-printed pills that effectively release a hair loss treatment drug over 24 hours.

Genetic analysis of rabbits identified key genes for traits like coat color, body size, and fertility.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Cancer can hijack the body's cell repair system to promote tumor growth, and targeting this process may improve cancer treatments.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

RV3466F lotion significantly reduces hair loss and improves acute telogen effluvium.

The immune system plays a key role in tissue repair, affecting both healing quality and regenerative ability.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Stem cell niches are adaptable and key for tissue maintenance and repair.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Minoxidil effectively treats hair loss, especially androgenetic alopecia, but needs more research for better understanding.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

Platelet-Rich Plasma (PRP) could potentially help regrow hair in people with Alopecia Areata, but more research is needed to confirm its effectiveness.

Sex hormones, especially estradiol, can change chicken feather shapes and colors.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Researchers identified genes and proteins that may influence wool thickness in sheep.

Hydroxychloroquine effectively treated twenty-nail dystrophy in a patient with alopecia areata.

iNOS contributes to hair loss in obese diabetic mice and blocking it may encourage hair growth.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.